Post-Market Drug Surveillance Research Methods Are Focus Of Reagan-Udall Program

01 Feb 2013

The Reagan-Udall Foundation has established an organizing committee to help inform the design and structure of what its Innovation in Medical Evidence Development and Surveillance program’s post-market research methods should look like and develop the IMEDS charter.

The Reagan-Udall Foundation is developing a program called Innovation in Medical Evidence Development and Surveillance (IMEDS) focused on bringing together work on surveillance research methods in order to facilitate post-market evidence generation for drugs and other medical products.

Created by Congress in 2007, the Reagan-Udall Foundation is a public-private initiative intended to advance FDA regulatory science. The IMEDS...